FDA Approves Johnson & Johnson Table-Integrated OTTAVA Robotic Surgery System
FDA grants De Novo authorization for Johnson & Johnson's OTTAVA robotic surgical system for general surgery procedures.
Johnson & Johnson got official permission from the government to sell a new robot that helps doctors do surgery more safely and precisely. This is good news because it means the company can now sell something totally new, which could help more patients and make the company money.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.